Document is current
Any future updates will be listed below
-
Authors
Wegen, Simone https://orcid.org/0000-0002-0361-728X
Nestle, Ursula
Zamboglou, Constantinos
Spohn, Simon K. B.
Nicolay, Nils Henrik
Unterrainer, Lena M.
Koerber, Stefan A.
La Fougère, Christian
Fokas, Emmanouil
Kobe, Carsten
Eze, Chukwuka
Grosu, Anca-Ligia
Fendler, Wolfgang P.
Holzgreve, Adrien
Werner, Rudolf
Schmidt-Hegemann, Nina-Sophie
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 25 February 2024
Accepted: 23 June 2024
First Online: 9 August 2024
Conflict of interest
: L.M. Unterrainer discloses personal fees (speaker honorary and/or advisory boards fees) from Astellas Pharma Inc., Novartis Radiopharmaceuticals, Telix-Pharmaceuticals, and ABX Radiopharmaceuticals. LMU is supported by the Clinician Scientist Program of the LMU Munich. W.P. Fendler reports fees from SOFIE Bioscience (research funding), Janssen (consultant, speaker), Calyx (consultant, image review), Bayer (consultant, speaker, research funding), Novartis (speaker, consultant), Telix (speaker), GE Healthcare (speaker), Eczacıbaşı Monrol (speaker), Abx (speaker), Amgen (speaker), and Urotrials (speaker) outside of the submitted work. S. Wegen, U. Nestle, C. Zamboglou, S.K.B. Spohn, N.H. Nicolay, S.A. Koerber, C. La Fougère, E. Fokas, C. Kobe, C. Eze, A.-L. Grosu, A. Holzgreve, R. Werner and N.-S. Schmidt-Hegemann declare that they have no competing interests.
